T

Thor Medical ASA
OSE:TRMED

Watchlist Manager
Thor Medical ASA
OSE:TRMED
Watchlist
Price: 4.31 NOK -0.69% Market Closed
Market Cap: 1.5B NOK

Wall Street
Price Targets

TRMED Price Targets Summary
Thor Medical ASA

Wall Street analysts forecast TRMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRMED is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.

Lowest
Price Target
5.05 NOK
17% Upside
Average
Price Target
5.1 NOK
18% Upside
Highest
Price Target
5.25 NOK
22% Upside
Thor Medical ASA Competitors:
Price Targets
XFOR
X4 Pharmaceuticals Inc
123% Upside
688105
Nanjing Vazyme Biotech Co Ltd
44% Upside
VCEL
Vericel Corp
57% Upside
IMMU
Mendus AB (publ)
242% Upside
ADAG
Adagene Inc
414% Upside
EXEL
Exelixis Inc
8% Upside
196170
Alteogen Inc
22% Upside
IKT
Inhibikase Therapeutics Inc
328% Upside

Revenue
Forecast

Revenue Estimate
Thor Medical ASA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Thor Medical ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Thor Medical ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRMED's stock price target?
Price Target
5.1 NOK

According to Wall Street analysts, the average 1-year price target for TRMED is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.

Back to Top